Hualan Biological Engineering
002007.SZ
#3032
Rank
A$6.60 B
Marketcap
$3.61
Share price
0.06%
Change (1 day)
-29.02%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): A$0.35 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are A$0.69 Billion. In 2023 the company made an earning of A$0.45 Billion, an increase over its 2022 earnings that were of A$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.35 B-20.85%
2023 A$0.45 B39.21%
2022 A$0.32 B-19.12%
2021 A$0.40 B-17.9%
2020 A$0.49 B37.11%
2019 A$0.35 B11.71%
2018 A$0.31 B50.84%
2017 A$0.21 B1.1%
2016 A$0.20 B23.49%
2015 A$0.16 B8.37%
2014 A$0.15 B10.83%
2013 A$0.14 B54.56%
2012 A$91.52 M-17.03%
2011 A$0.11 B-41.34%
2010 A$0.18 B6.15%
2009 A$0.17 B261.3%
2008 A$49.03 M85.75%
2007 A$26.39 M49.27%
2006 A$17.68 M56.98%
2005 A$11.26 M34.28%
2004 A$8.38 M